Dallas, Texas: StockGuru announces The StockGuru Spotlight for Wednesday, July 11, 2012. Included in today’s Spotlight are North American Nickel Inc. (OTCBB: WSCRF), White Mountain Titanium Corporation (OTCBB: WMTM), Ohr Pharmaceutical (OTCBB: OHRP) and Preventia, Inc. (OTCBB:PVTA).
North American Nickel Inc. (OTCBB: WSCRF) North American Nickel (“NAN”) noted that on June 28, 2012 the Geological Survey of Denmark and Greenland (“GEUS”) announced that the Maniitsoq Structure represents “The remains of a gigantic, three-billion-year-old meteorite impact…” This announcement by GEUS coincided with the same day publication of a paper on this subject in the prestigious journal Earth and Planetary Science Letters (Elsevier) authored by Adam A. Garde, Iain McDonald, Brendan Dyck and Nynke Keulen.
In the paper, the authors postulate that crustally contaminated intrusions of the Greenland Norite Belt (GNB) are products of the impact. The GNB has been the focus of the NAN’s work at Maniitsoq since it initiated the project last year. NAN is interested in the GNB because it is aerially extensive (the main belt is over 70 km long and up to 15 km wide), is comprised of noritic intrusions that show evidence of crustal contamination (believed to be important in the formation of nickel-copper sulphide ores), hosts numerous historical high-grade nickel occurrences (e.g. 9.85 m averaging 2.67% Ni and 0.60% Cu at the Imiak Hill showing) and is remarkably under-explored.
For more information on WSCRF, please visit: http://stockguru.com//tag/wscrf/
White Mountain Titanium Corporation (OTCBB: WMTM) reports that further to the News Release of May 31, 2012, the Company has now received initial analytical results from a surface rock sampling program carried out on three new rutile target areas and one of four known prospects. Samples were submitted for whole rock analysis using XRF and results are set out below for Hippo Ear, Algodon, and Quartz Creek and Chascones Prospect.
These initial rock sampling results for the three new rutile target areas as well as the Chascones prospect are similar to historic results obtained on the Las Carolinas and La Cantera prospects which are located along strike and to the northeast of Chascones. Las Carolinas contains the Cerro Blanco project’s current estimated rutile resource and La Cantera is the next prospect scheduled for drilling. At La Cantera, an historic surface rock sampling program comprised of 149 samples had an average grade of 1.63% and maximum grade of 3.49% TiO2.
For more information on WMTM, please visit: http://stockguru.com//tag/wmtm/
Ohr Pharmaceutical (OTCBB: OHRP) today announced positive results from a long term safety study of Squalamine eye drops being developed for the treatment of the wet form of age-related macular degeneration (“wet-AMD”) and other ophthalmic neovascular disorders. The data from the study indicates that the novel eye drop is safe when applied to the eye with no signs of ocular or systemic toxicity on long term administration. The Squalamine eye drop program was recently awarded Fast Track designation by the U.S. FDA, and the company presented data at scientific meetings which highlighted the clinical relevance of Squalamine eye drops for the treatment of wet-AMD.
“We are excited with the continued positive results being generated on our Squalamine eye drop program demonstrating its safety, tolerability, and consistent therapeutically relevant concentrations in the eye,” stated Dr. Irach B. Taraporewala, CEO of Ohr. “An eye drop for wet-AMD would be transformational for the large patient population currently taking chronic treatments of Lucentis® or Eylea® injected directly into the eye. The program continues to progress rapidly and we expect to initiate a clinical Phase II trial in Q3 2012 for the treatment of wet-AMD.”
For more information on OHRP, please visit: http://stockguru.com//tag/ohrp/
Preventia, Inc. Launches Operational Unit to Create Dematerialized Financial Products
Preventia, Inc. (OTCBB:PVTA) has launched an operational unit subsidiary, Preventia Group Corporation, to create and distribute financial products. Preventia expects to immediately develop and market financial products for dematerialization reaching out to firms positioned to run their own electronic trading operations. By licensing the patented System, and/or facilitating its use by others, Preventia’s Canadian subsidiary will monitor the System and its users to assure its related intellectual property and System IP is properly and adequately protected and otherwise enforced.
Preventia’s CEO, Robert Stevens states, “We are excited with the opening of our new operational subsidiary and the financial products planned. The real time transactions through the patented electronic trading System and clearing of each individual designed financial instrument will be vigorously protected by our U.S. patent 8,165.952, under which we hold all rights exclusively. The necessity of patent protection must be vigorously maintained throughout the lifetime of each of the created instruments, and the jurisdictions that trade them, whether in secondary or primary form. I believe the corresponding licensing and recurring revenues from our approach will reflect in the dramatic growth of Preventia.”
For more information on PVTA, please visit:
http://stockguru.com//tag/pvta/
What is The StockGuru Spotlight?
Many companies covered in The StockGuru Spotlight have positive increases in both volume and share price. While this is not true in all cases, StockGuru strives to cover companies in The StockGuru Spotlight that are worthy of our readers attention.
StockGuru looks for potential break-out candidates in The StockGuru Spotlight. Many of these companies have had recent news and appear to be getting the attention of investors. StockGuru does not typically feature companies in The StockGuru Spotlight that are compensating StockGuru for this coverage. There are times when StockGuru covers a stock in The StockGuru Spotlight that had previously compensated StockGuru. Where that is the case, a proper disclosure is included below. StockGuru and its partners, employees and writers never hold shares, short positions, warrants or any other current position in a stock featured in The StockGuru Spotlight.
To feature a company in The StockGuru Spotlight please contact the Publisher at [email protected]. If our reader is a key person for a publicly traded company, StockGuru can consider that company for either a StockGuru Spotlight or a StockGuru Profile. Please contact the StockGuru Publisher John Pentony at this email address: [email protected].
Stockguru.com (“SG”) provides its members with the latest news, press releases, and trade alerts for all the companies highlighted on the site StockGuru.com. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. The companies that are discussed in this opinion have not approved the statements made in this release or blog post. This release or blog post contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein. CRWG Disclosure: StockGuru is covering news for CRWG in a contract with the Company direct. We have been paid a total of six thousand two hundred dollars for coverage of press releases to our network for thirty days. We have never owned shares of CRWG. We hold no shares, warrants or options on shares. We have no long or short position of any kind. StockGuru is not a registered investment adviser or a broker/dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. StockGuru | 1601 Berwick Drive | McKinney, Texas 75070.